Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Investment and Collaboration Strategies in Cell and Gene Therapy

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio


Follow This Show

If you liked this show, you should follow Pharma Talk Radio.

This panel, first recorded at the 2022 IO360° Summit addressed:

  • What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available?
  • Venture company perspectives on what they are investing in and why? • What science needs to be seen in order to invest in either a startup or IPO?
  • What are investors/pharma partners looking for and how does that inform what people should be doing?
  • How do we think about partnerships between organizations?

Moderated by:

Michael Polansky, CEO, Parker Group


  • Mark Bonyhadi, PhD, Senior Advisor, Qiming Venture Partners
  • Elaine Cheung, SVP, Corporate Strategy & Business Development, Lyell Immunopharma
  • Arjun Goyal, MD, MPhil, MBA, Co-founder and Managing Director, Vida Ventures

Learn more about the IO360° Summit at www.io360summit.com

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled